Skip to search formSkip to main contentSkip to account menu

N-(2-Carboxyphenyl)Retinamide

Known as: all-trans-N-(2-Carboxyphenyl)retinamide 
A phenylretinamide and synthetic retinoid analogue. N-(2-carboxyphenyl)retinamide may bind to and activate retinoic acid receptors (RARs), thereby… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells.
Women with germline mutations in the breast cancer susceptibility gene BRCA1 are at an increased risk of developing breast cancer… 
2005
2005
Correlation of in vitro chemopreventive efficacy data from the human epidermal cell assay with animal efficacy data and clinical trial plasma levels
The human epidermal cell (HEC) assay, which uses carcinogen exposed normal skin keratinocytes to screen for cancer prevention… 
2003
2003
Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
Fenretinide (4-HPR) is a retinoid analogue with antitumor and chemopreventive activities. In addition to 4-HPR, there are several… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)